Vaginitis is a leading cause of clinic visits by women, with more than 10 million per year in the United States.
1 Limitations with traditional test methods contribute to poor diagnosis, inappropriate treatment, and persistent symptoms.
2High performing PCR tests are available for large, batch analyzers but have limited practical use for clinicians due to a lag in reportable results, making appropriate same day treatment a challenge.
3Challenges remain:- Detection and differentiation of organisms associated with bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV), which all present with similar symptoms
- Mixed and co-infections of BV, VVC, and TV are common, further complicating diagnosis and the guidance of appropriate treatment4,5
- Testing options that offer accurate and objective test results to drive timely and appropriate treatment for improved patient management
1 Brown H, et al. Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness. Population Health Management 2020 23:S1, S-3-S-12
2 Hillier SL, et al. Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis. 2021 May 04; 72(9) 1538-1543
3 Gaydos CA, et al. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management: Report of a Randomized Clinical Trial. Ann Emerg Med. 2019 Jul; 74(1) 36-44
4 Gaydos CA, et al. Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstetrics & Gynecology: July 2017 - Volume 130 - Issue 1 - p 181-189 doi: 10.1097/ AOG.0000000000002090
5 Schwebke J, et al. Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study. J Clin Microbiol 58:e01643-19.